N syndrome

Common Name(s)

N syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "N syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "N syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "N syndrome" returned 140 free, full-text research articles on human participants. First 3 results:

Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
 

Author(s): Paweł Krzesiński, Beata Uziebło-Życzkowska, Grzegorz Gielerak, Adam Stańczyk, Katarzyna Piotrowicz, Wiesław Piechota, Paweł Smurzyński, Andrzej Skrobowski

Journal: Adv Clin Exp Med. ;26(2):295-301.

 

N-terminal pro-brain natriuretic peptide (NT-proBNP) release is associated with left ventricular expansion and pressure overload. Elevation of serum levels of natriuretic peptides is observed in patients with impaired as well as preserved left ventricular systolic function. High NT-proBNP ...

Last Updated: 9 Aug 2017

Go To URL
N-Methyl-D-Aspartate Receptors, Ketamine, and Rett Syndrome: Something Special on the Road to Treatments?
 

Author(s): David M Katz, Frank S Menniti, Robert J Mather

Journal: Biol. Psychiatry. 2016 May;79(9):710-2.

 

Last Updated: 15 Apr 2016

Go To URL
The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.
 

Author(s): Fang-Yang Huang, Hua Wang, Bao-Tao Huang, Wei Liu, Yong Peng, Chen Zhang, Tian-Li Xia, Peng-Ju Wang, Zhi-Liang Zuo, Yue Heng, Rui-Shuang Liu, Xiao-Bo Pu, Yi-Yue Gui, Shi-Jian Chen, Ye Zhu, Mao Chen

Journal:

 

Whether body composition is associated with the N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and its prognostic performance in acute coronary syndrome (ACS) remains unknown. We aimed to investigate the influence of body composition on the NT-proBNP level and its prognostic ...

Last Updated: 6 Apr 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "N syndrome" returned 5 free, full-text review articles on human participants. First 3 results:

Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of "N-Terminal Modification" to "Fatty Acid Occupation" of Albumin.
 

Author(s): Ismail Oran, Bulent Oran

Journal: Dis. Markers. 2017 ;2017():5692583.

 

Ischemia-modified albumin (IMA) is assumed "N-terminal modified" albumin which is generated immediately following myocardial ischemia. The diagnosis of IMA is based on reduced cobalt binding affinity to albumin which is attributed mainly to incapability of cobalt to bind at albumin's ...

Last Updated: 30 Mar 2017

Go To URL
Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans.
 

Author(s): Chao-Wei Huang, Yi-Shan Chien, Yu-Jen Chen, Kolapo M Ajuwon, Harry M Mersmann, Shih-Torng Ding

Journal:

 

The incidence of obesity and its comorbidities, such as insulin resistance and type II diabetes, are increasing dramatically, perhaps caused by the change in the fatty acid composition of common human diets. Adipose tissue plays a role as the major energy reservoir in the body. An ...

Last Updated: 13 Oct 2016

Go To URL
Use of n-3 PUFAs can decrease the mortality in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.
 

Author(s): Xiao Wan, Xuejin Gao, Jingcheng Bi, Feng Tian, Xinying Wang

Journal:

 

There have been several meta-analyses evaluating the effect of n-3 polyunsaturated fatty acids (PUFAs) in critically ill patients, but of these, none focused on patients with systemic inflammatory response syndrome (SIRS). The objective of this meta-analysis was to evaluate the effect ...

Last Updated: 20 May 2015

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Impact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide
 

Status: Not yet recruiting

Condition Summary: Acute Coronary Syndrome

 

Last Updated: 29 Jul 2017

Go to URL
Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation
 

Status: Recruiting

Condition Summary: Constipation; Irritable Bowel Syndrome

 

Last Updated: 21 Aug 2017

Go to URL
Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)
 

Status: Recruiting

Condition Summary: Obese; Metabolic Syndrome

 

Last Updated: 28 Sep 2017

Go to URL